Medical Journal. The British NICE has published its official position on biosimilar drugs; in its guides, it will not differentiate between the original and its biosimilar, applying the same recommendations to both. When prescribing, the cheapest option should be chosen, he adds. (NICE position on biosimilars)
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
